One year ago, The Medicare Negotiation and Competitive Licensing Act was introduced to increase transparency and allow the government to negotiate drug pricing with manufacturers. Recently, the Senate Finance Committee introduced the Prescription Drug Pricing Reduction Act of 2019 to address the high costs of...
After President Trump entered office, the administration repeatedly delayed the implementation of a 340B rule that was finalized at the end of the Obama administration. Recently, the Trump administration has indicated that they plan to not only implement the rule but also accelerate...
Despite multiple delays, the Secretary of Health and Human Services, Alex Azar, recently renewed his agencies plan to release regulations for setting 340B drug discount program drug prices. While speaking to the hospital trade group, 340B Health, Azar addressed the provider’s concerns that the multiple delays...